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Introduction 
Cervical Spondylosis is now becoming a 
significant threat to the working population due to its 
progressive nature of the disease. Modern science 
provides various types of medical and surgical therapies 
for Cervical Spondylosis but it is realized that more 
research is needed for the treatment of Cervical 
Spondylosis satisfactorily. 
A healthy life has been cherished wish of man 
since ages, but now a day due to fast developing 
technological era, sedentary lifestyle and lack of time, 
people cannot concentrate on their proper regimens and 
facing so many hurdles. One such hurdle is Cervical 
Spondylosis (1). Occupational stress, poor posture in 
sitting or sleeping, day sleep, excessive travelling etc. 
lead to spondylitic changes in cervical spines.  
Treatment is usually conservative in nature; 
Surgery is occasionally performed and taking long term 
treatment of modern medicine the chronic use of 
analgesic affects body badly (2). 
Many of the treatment modalities for cervical 
spondylosis have not been subjected to rigorous, 
controlled trials. Surgery is advocated for cervical 
radiculopathy in patients who have intractable pain, 
progressive symptoms, or weakness that fails to 
improve with conservative therapy. Surgical indications 
for cervical spondylotic myelopathy remain somewhat 
controversial, but most clinicians recommend operative 
therapy over conservative therapy for moderate-to-
severe myelopathy. 
According to Ayurveda, Manyasthambha is 
correlated with Cervical spondylosis which is 
Vatakapha predominant disorder as it resides in 
Kasherukagata sandhi and Majja. So, Vatahara and 
Brumhana Chikitsa are advised in this entity by our 
Acharyas. Charakacharya described Panchatikta 
Dravyas and Panchatikta Ksheer and Ghrita Basti in 
Asthyashrit Vyadhi (3). In Asthivaha Strotodushti 
Chikitsa Panchatikta Dravya Siddha Ksheer Basti and 
Sarpi are mentioned and since all these are Rasayana 
for Asthi Dhatu. He had also mentioned the importance 
of Sthanic Snehana, Swedana and Basti in Vatdosha 
Upkramass.(4)  
The Nasya Karma is also considered as the best 
and the most specific procedure for diseases of the head 
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Visesannasyamisyate” (5). The rich vascular plexus of 
nasal cavity provides a direct route into blood stream 
for medications that easily cross mucus membrane. 
According to Acharya Charaka, Nose is the gateway of 
Shira (6). Same is stated by Vagbhatta the nasal passage 
is considered as the portals of the head “Nasa hi Siraso 
Dwaram” (7).  
 According to above concepts all drugs 
measures introduced through the nose spread 
throughout the head and its constituent parts and may 
accordingly influence all the Doshas and diseases 
situated in these parts (8).  Manya shoola lakshana is 
explained as Greevayah Paschatbhaga Shoola (9). 
Sushruta had used the words Manyagraha and 
Manyastambha synonymously and described 
Manyastambha in Urdhvajatrugata Vata nanatmaja 
vikara (10) as Manyaha kriyahani. He described the 
involvement of Kaphavruta Vata in the pathogenesis of 
Manyasthambha(11). Manyastambha is told as Vata 
kaphaja even though it is included in Vataja nanatmaja 
Vyadhi according to Sharangadhara (12).  
Bhavaprakasha, Yogaratnakara, Sushruta 
Samhita, Bhaishajya Ratnavali all advised the use of 
Nasya for its management. Panchatikta Dravyas i.e. 
Guduchi (Tinospora cordifolia (Thunb.) Miers), Nimb 
( A z a d i r a c h t a i n d i c a A . J u s s ) , V a s a 
(Adhathoda vasica Nees.), Kanatakari (Solanum 
X a n t h o c a r p u m S c h a r d . W e n d l ) , P a t o l 
(Trichosanthes dioica ROXB) involved in Panchtikta 
Ghrita preparation are Rasayana for Asthidhatu. 
Charakacharya described Panchatikta Dravyas in 
Asthivaha Strotodushti Chikitsa in the form of 
Ksheerbasti and Sarpi (13).  
Rationale 
In this period of modernization and fast life, 
people undergo many unwanted practices like improper 
sitting posture for long time in offices, continuous work 
in one posture and over exertion, load bearing 
movements during travelling and sports – all these 
factors create undue pressure and compressive injury to 
the spine and play an important role in producing 
disease like cervical spondylosis. Cervical spondylosis 
is a degenerative condition of the cervical spine where it 
may lead to Cervical spondylotic myelopathy (14).  
Main symptoms are Pain & Stiffness in neck, 
radiating pain into arms, headache, vertigo, tingling 
sensation, numbness etc. It disturbs   daily routine & 
overall life of patient.  
This disease is now becoming a significant 
threat to the working population due to its progressive 
nature. Modern medical science provides various types 
of medical and surgical therapies but is seen that none 
of therapy is satisfactory in cervical Spondylosis. All 
treatment modules just provide symptomatic relief for 
short period of time. Hence Ayurveda now coming into 
focus for chronic types of conditions. 
Here in initial stages of the disease Kapha 
Dosha involvement is present. The Kapha vitiation 
causes obstruction of Vata. Main factors involving in its 
pathogenesis are Vata (Vyanavata) and Kapha 
(Shleshaka Kapha). Dushyas occurring in it are Asthi, 
majja, snayu, mamsa. Hence, the drugs having Vata 
Kaphahara properties should be administered. They 
should have property to prevent the degeneration of 
bones and promote the regeneration. According to 
Charakacharya, Basti is prime treatment for Vata 
diseases (15). By taking into consideration all above 
facts, in this study use of Panchtikta ghrita(16) was 
used for Vasti and Nasya in patients having cervical 
spondylosis. 
Specific objectives 
• To study the effect of Panchtikta Ghrita Matra Vasti 
in Cervical spondylosis 
• To study the effect of Panchtikta Ghrita Marsha 
Nasya in Cervical spondylosis 
• To compare effects of the Panchtikta Ghrita Matra 
Vasti and Panchtikta Ghrita Marsha Nasya in 
Cervical Spondylosis 
Methods 
Trial design- Open randomized parallel 
comparative clinical study (Phase 2/3).  30 patients 
were randomly (n=15 in each group) recruited in the 
study in two groups. In group A, patients were treated 
with Panchtikta Ghrita Matra Vasti and in group B with 
Panchtikta Ghrita Marsha Nasya. Not a single change 
was done after trial commencement. 
Participants 
Eligibility criteria for participants: 
Inclusion criteria - Patients of either sex with presenting 
classical symptoms of cervical spondylosis (17), X-ray 
suggesting cervical spondylosis (18) confirmed by 
qualified radiologist, Patients above 20 years and <60 
years, Patient who can make neck extension up to 45-
degree angle. 
Exclusion Criteria - Age group below 20 years and 
above 60 years, Cervical Spondylosis with myelopathy 
and radiculopathy (ICD 10 criteria M47.8), 
Contraindication and previously treated with Vasti 
therapy (19), Nasya Anarha (20), Matra Sneha Vasti 
Anarha, Pregnant and lactating mothers, Recent 
cervical, spinal, or shoulder surgery or implanted 
instrumentation or previous surgery for cervical 
spondylotic myelopathy, Stenosis of the spinal canal, 
Patients suffering from any infectious disease (like 
tuberculosis), metabolic disease (like diabetes mellitus 
and hypothyroidism), or chronic diseases (such as 
rheumatoid arthritis, systematic lupus erythromatous 
and ankylosing  spondylitis) 
Settings and locations where the data were collected: 
Concerned patients were selected from the 
Panchakarma OPD and IPD of MGACH & RC, Salod 
(H) with preset diagnostic criteria and who were willing 
to give informed consent.  
Panchtikta Ghrita which is trail drug is 
supplied by Kamdhenu Panchgavya Govidnyana 
Anusandhana Kendra, Deolapar, Nagpur, Maharashtra 
where it was prepared as per Snehapaka vidhi 
mentioned by Sharangdhara in Sh. Sam. Madh. Kh. – 
ch.9. 
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Table 1: Intervention of Panchatikta Ghrita in both 
the groups 
Outcomes 
Primary outcome of this trial was to compare 
efficacy of Panchtikta Ghrit Marsha Nasya and 
Panchtikta Ghrit Matra Basti in Manya Stambha 
(Spondylosis) in terms of relief in symptoms of 
Cervical Spondylosis and Improvement(reduction) in 
Neck Disability Index  (NDI) score & Secondary 
outcome was to find out radiological changes in 
cervical spondylosis in both groups. Assessment of the 
patients was done before intervention, just after 
completion of interventions (on 8th day) and on the 
follow up day i.e. 21th day as follows. 
7.1 Subjective Parameters:  
1) Manya shoola (Pain in cervical region):  
0=No Pain  
1=Pain in neck only after neck movements  
2=Continuous pain in neck which further worsen 
after neck movements 
3= Continuous Pain in neck and it radiates towards 
either upper limb and disturbed the sleep 
2) Manya sthambha (Stiffness in Cervical region): 
0=No Stiffness, 
1=Stiffness up to 1 hour  
2=Stiffness up to 2-3 hours  
3=Stiffness up to more than 4-6 hours 
Objective Parameters: 
Neck disability Index: 
It is a questionnaire used to find out the level of 
disability of neck before and after treatment. It consists 
10 questions such as pain intensity, personal care (like 
washing dressing), lifting, reading, headache, 
concentration, work, driving, sleeping, recreation, etc., 
each having 6 questions (0-5 points). This index was 
assessed before the day of intervention, just after 
completion of interventions (on 8th day) and on the 
follow up day i.e. 21st day as follows. 
X-ray cervical spines (Anteroposterior and lateral 
view): 
Degenerative changes of Cervical spondylosis 
with mark reduction in cervical spines was assessed 
through X-ray Cervical regions (AP & Lateral view) 
before intervention and on the follow up visit i.e. on 21st 
day. 
Sample size: Total 30 patient were recruited in the 
study, 15 patients per group. 
Randomization/ Sequence generation: Randomization 
was done by simple lottery method 
Implementation- Maintenance of sequence of random 
allocation, enrollment of patients and assignment of 
intervention to patients was done by principal 
investigator. 
Statistical methods 
Statistical methods used to compare groups for 
primary and secondary outcomes. The data obtained in 
clinical study was subjected to statistical tests paired, 
unpaired t-test (software sigma stat version 0.2) and 
analyzed in two parts as; the subjective criteria were 
assessed before treatment (V1), after treatment(V2), 
after 14 days (at follow up –V3) by the Wilcoxon 
signed Rank test. Neck disability index was also 
assessed on same visits with Paired & unpaired t-test 
(for comparison before &after treatment in same group 
& to compare between group respectively) using Graph 
pad prism software version 7.0 version. P value < 0.05 
was considered significant.  Radiological findings of X-
ray were assessed before starting treatment and on 28th 
day of study.  
All patients were instructed to take analgesic 
according to their choice if pain was aggravated during 
trial & If there was further or any complication such as 
tingling or vertigo arises then such patient will be 
allowed to undergo physiotherapy. But there were no 
such incidences occur for any patient. 
Results 
30 patients recruited in this clinical trial (15 in 
each group), all patients received intended treatment for 
allotted duration and were analyzed for the primary & 
secondary outcomes. No patient was drop out from the 
study and no any adverse event was noted. From the 
collected data  from  all 30 patients registered in this 
trial  reflected that  there was maximum  patients  20 
(66.66%) were from age group  40-50, 18 patients 
(60%) were females & from urban population, 25 
(83.33%) were had  sedentary job,20 patients (67%) 
were Hindus, 11 patients (37%) were patients suffered 
from disturbed sleep, 16 patients (55%) had disturbed 
bowel habit & 21  patients (78%) were of vatapradhan 
pittanubandhi prakruti.  
Group A Group B
Intervention
Panchtikta 
Ghrita Matra 
Vasti was 
administered 
after 
preparatory 
procedure
Administration of Marsha 
Nasya with lukewarm 
Panchtikta Ghrita 
(Mrudu paka) with the 
dose of 8 Bindu 
(approximate 4 ml) in 
each nostril one by one 
with the help of dropper 
at 8:30 am for 7 
consecutive days (21).
Root of 
administration Anal Nasal
Dosage
60 ml per 
day for 
consecutive 
7 days
8 drops (4 ml) in each 
nostril per day for 
consecutive 7 days
Duration of 
intervention 7 days 7 days
Follow up 
Period: 21 days 21 days
Total Study 
duration 28 days 28 days
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Assessment of the total effect of the therapy 
Table 2: Showing Statistical analysis of effect of both 
interventions on Manyashoola  
(Pain in cervical region) 
*S- Significant, NS- Not Significant 
Inference:  
From above table and graph, it reflects that in 
Group A, there were 3, 8 and 4 patients had 
Manyashoola having Grade 2, 3 and 4 respectively. 
While in Group B, there were 6, 6 and 3 patients with 
Manyashoola having Grade 2, 3 and 4 respectively. 
From the observation, it is clear that in Group A, the 
maximum number of patients with Manyashoola having 
Grade 3. However, in Group B, there were maximum 
patients with Manyashoola having Grade 2 and 3. In 
group A,70 % patients got relief just after intervention 
& 80% persons   got relief   after intervention in group 
B. 
The non significant Chi-square value (2.39) and 
P value (P= 0.30) while comparison between Group A 
and Group B before treatment, it shows that there was 
uniform distribution. 
On comparing just after intervention between 
Group A and Group B, significant Fisher Exact value 
(2.40) and P value (P= 0.011) shows that there is 
significance between two groups, that means Marsh 
Nasya with Panchtikta Ghrita is more effective than 
Matra Vasti with Panchtikta Ghrita to reduce the 
symptom of Manya shoola. 
In Follow up visit, though there was significant 
relief in Shirashoola after intervention in each group, 
but after comparison between two groups, the 
significant Fisher Exact value (2.33) and P value (P= 
0.026) shows that comparative more effect of Marsh 
Nasya with  Panchtikta Ghrita  than  the effect of 
Matra Vasti  with Panchtikta Ghrita even after 21 days 
also. 
Table 3: Showing Statistical analysis of effect of both 
interventions on Manyasthambha  
(Stiffness in Cervical region) 
                  *S- Significant, NS- Not Significant 
Inference:  
From above table and graph, it reflects that in 
Group A, there were 2, 8 and 5 patients had 
Manyasthambha having Grade 2, 3 and 4 respectively. 
While in Group B, there were 1, 5, 7 and 4 patients with 
Manyasthambha having Grade 0, 2, 3 and 4 
respectively. From the observation, it was clear that in 
both groups, the maximum number of patients with 
Manyasthambha having Grade 3.  
From the above table, it again reflects that there 
were 6, 6 and 3 patients with Manyasthambha in Group 
A having Grade 1, 2 and 3 respectively which shows 
that after Matra Vasti with Panchtikta Ghrita, there 
were 80% patients got relief from Manyasthambha. 
This means after intervention in control group, the 
intensity of Manyasthambha was reduced significantly. 
In the follow up visit of same group, the effect was 
going on and total number of patients got relief from 
Manyasthambha. 
From the above table, it again reflects that there 
were 1, 8, 5 and 1 patient with Manyasthambha in 
Group B having Grade 0, 1, 2 and 3 respectively. After 
Marsh Nasya with Panchtikta Ghrita there were 90 % 
patients got relief from Manyasthambha. This means 
after intervention in trial group, the severity of 
Manyasthambha was reduced significantly. In the 
follow up visit of same group, the effect was going on 
and there was not a single patient with Manyasthambha 
and there was no recurrence. 
The non-significant Fisher Exact value (3.63) 
and P value (P= 0.30) while comparison between Group 
A and Group B before treatment shows that there was 
uniform distribution. 
On comparing just after intervention between 
Group A and Group B, the significant Fisher Exact 
value (2.50) and P value (P= 0.021) shows that there 
was significant difference between two groups, that 
means Marsh Nasya with Panchtikta Ghrita was more 
Manya 
shoola Before t/t After t/t
Follow Up 
Period
Group A
Grade 0 0(0%) 13(70%) 10(66.66%)
Grade 1 0(0%) 2(30%) 5(33.33%)
Grade 2 3(20%) 0(0%) 0(0%)
Grade 3 8(53.3%) 0(0%) 0(0%)
Grade 4 4(26.7%) 0(0%) 0(0%)
Fisher Exact - 3.600 3.733
p-value - <0.001, S <0.001, S
Group B
Grade 0 0(0%) 11(80%) 15(100%)
Grade 1 0(0%) 4(20%) 0(0%)
Grade 2 6(40%) 0(0%) 0(0%)
Grade 3 6(40%) 0(0%) 0(0%)
Grade 4 3(20%) 0(0%) 0(0%)
χ2-value - 2.933 3.333
p-value - <0.001, S <0.001, S
Comparison between Group A and Group B
Fisher Exact 2.39 2.400 2.333
p-value 0.30, NS 0.011, S 0.026, S
Manya 
Sthambha Before t/t After t/t
Follow Up 
Period
Group A
Grade 0 0(0%) 12(80%) 15(100%)
Grade 1 0(0%) 3(20%) 0(0%)
Grade 2 2(13.3%) 0(0%) 0(0%)
Grade 3 8(53.3%) 0(0%) 0(0%)
Grade 4 5(33.3%) 0(0%) 0(0%)
Fisher Exact - 3.333 3.600
p-value - <0.001, S <0.001, S
Group B
Grade 0 1(6.7%) 14(90%) 15(100%)
Grade 1 0(0%) 1(10%) 0(0%)
Grade 2 5(33.3%) 0(0%) 0(0%)
Grade 3 7(46.7%) 0(0%) 0(0%)
Grade 4 2(13.3%) 0(0%) 0(0%)
Fisher Exact - 3.733 3.933
p-value - <0.001 <0.001
Comparison between Group A and Group B
Fisher Exact 3.63 2.50 2.40
p-value 0.30, NS 0.021, S 0.103, NS
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effective than group A to reduce the symptom of 
Manyasthambha. 
In Follow up visit, though there was significant 
relief in Manyasthambha after intervention in each 
group and  after comparison between two groups, the 
non-significant Fisher Exact value (2.40) and P value 
(P= 0.103) shows that  group with Marsh Nasya with 
Panchtikta Ghrita  was as effect as that of group A  for 
relief in Manya Sthmbha after 21 days. 
Table 4: Calculation of Neck Disability Index (NDI) score before and after the treatment in both groups 
Table 5: Statistical analysis of NDI score in both the groups  
*S- Significant, NS- Not Significant 
The neck disability index was found significant in both the groups. However, more significant in group B. 
There was no restriction of food or regimen while administering Matra Basti; it can be administered 
continuously in all seasons. Unlike Anuvasana Basti, Matrabasti can be administered to Bala, Vriddha and in Alpagni 
conditions.  There is no Pariharakala for this type of Basti. There were not a single excluded or withdrawn from the 
study after randomization.  
Recruitment: Total duration of intervention was 7 days which was followed by visit after 14 days i.e. on the 21st day.  
Outcomes and estimation 
The symptoms were Cervical spondylosis was significantly reduced after interventions in both groups and this 
relief in symptoms was persisted even on the follow up visit also in both groups. NDI score was found better in both 
the groups, but mean score of NDI was suggestively improved in Group B (before 45.03, after 13.06) compare to 
Group A (before 46.26, after 23.06) .But there was no significant changes  in radiological findings even just after 
interventions  and on follow up visit (P<0.05). Though there was significant relief in symptoms of Cervical 
spondylosis   as well as significant reduction in Neck disability index in both groups. However, both these positive 
findings were significantly more in Group B i.e. Marsh Nasya with Panchtikta Ghrita. 
Group A Group B
SN Before After SN Before After
1 23 13 1 23 4
2 24 13 2 24 8
3 21 12 3 23 11
4 24 14 4 22 11
5 23 12 5 24 11
6 21 11 6 22 4
7 23 12 7 23 4
8 22 11 8 24 10
9 22 8 9 24 4
10 23 11 10 20 4
11 21 11 11 22 8
12 23 13 12 19 1
13 22 12 13 23 4
14 21 8 14 22 4
15 22 10 15 23 10
NDI 46.26 23.06 NDI 45.06 13.06
NDI score before treatment in both Groups
Group N Median 25% 75% T Value P Value
A 15 22 21.25 23 212 0.418B 15 23 22 23.75
Before & After the treatment NDI score in Group A
Treatment N Median 25% 75% T Value P Value
Before TT 15 22 21.25 23 -120.000 <0.001, SAfter TT 15 12 11 12.75
Before & After the treatment NDI score in Group B
Treatment N Mean Std Dev SEM T Value P Value
Before TT 15 22.533 1.457 0.376 20.992 <0.001, SAfter TT 15 6.533 3.42 0.883
NDI score after treatment in both Groups
Group N Median 25% 75% T Value P Value
A 15 12 11 12.75 323 <0.001, SB 15 4 4 10
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Table 6: Observations of Hematological parameters in Group A (Matra Vasti treatment)  
Table 7: Observations of Hematological parameters in Group B (Marsh Nasya treatment) 
Parameter Treatment Name N Mean Std Dev SEM T value P value
HB%
BT 15 12.567 1.607 0.415 0.786 0.445
AT 15 12.387 1.603 0.414
Difference 15 0.18 0.887 0.229
TLC
BT 15 6226.667 1084.611 280.045 -0.579 0.572
AT 15 6440 1501.808 387.765
Difference 15 -213.333 1427.719 368.635
N
BT 15 56.8 6.603 1.705 -2.219 0.043
AT 15 59.867 6.278 1.621
Difference 15 -3.067 5.351 1.382
L
BT 15 37.6 6.045 1.561 0.935 0.366
AT 15 36.267 5.97 1.541
Difference 15 1.333 5.525 1.427
Total RBC
BT 15 4.753 0.691 0.178 -0.783 0.447
AT 15 4.803 0.672 0.174
Difference 15 -0.0507 0.251 0.0647
T. Platelet
BT 15 260733.3 96703.87 24968.83 -0.217 0.831
AT 15 262466.7 90590.02 23390.24
Difference 15 -1733.33 30918.02 7982.998
ESR
BT 15 29 22.656 5.85 2.098 0.055
AT 15 24.067 19.998 5.163
Difference 15 4.933 9.106 2.351
MCH
BT 15 25.9 5.487 1.417 0.301 0.768
AT 15 25.8 5.343 1.38
Difference 15 0.1 1.286 0.332
Parameter Treatment Name N Mean Std Dev SEM T value P value
HB%
BT 15 13.313 2.14 0.552 -0.289 0.777
AT 15 13.373 1.921 0.496
Difference 15 -0.06 0.805 0.208
TLC
BT 15 6800 1424.781 367.877 0.466 0.648
AT 15 6633.333 1468.073 379.055
Difference 15 166.667 1384.437 357.46
N
BT 15 58.533 6.046 1.561 -1.208 0.247
AT 15 61.4 8.007 2.067
Difference 15 -2.867 9.187 2.372
L
BT 15 34.467 5.317 1.373 0.787 0.444
AT 15 32.8 7.58 1.957
Difference 15 1.667 8.2 2.117
B
BT 15 3.4 2.501 0.646 0.000 1.000
AT 15 3.4 1.882 0.486
Difference 15 0 2.591 0.669
E
BT 15 3.267 2.282 0.589 0.837 0.417
AT 15 2.933 1.668 0.431
Difference 15 0.333 1.543 0.398
Total RBC
BT 15 4.611 0.676 0.175 -0.235 0.817
AT 15 4.625 0.688 0.178
Difference 15 -0.014 0.23 0.0595
ESR
BT 15 27 20.231 5.224 0.137 0.893
AT 15 26.533 22.627 5.842
Difference 15 0.467 13.228 3.415
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Table 8: Observations of Hematological parameters in Group A (Basti) & Group B (Nasya) before treatment 
Table 9: Observations of Hematological parameters in Group A (Basti) & Group B (Nasya) after treatment 
There was not significant difference found in hematological parameters and all the hematological values 
found normal during both the intervention.   
ESR was decreased insignificantly just after interventions in both the groups. But there was no statistically 
significant difference seen between the groups. (*p<0.05) 
Overall effect of therapy with Subjective Criteria: 
Table 10: Assessment on the basis of relief in subjective criteria 
From the above table, it reflects that when both groups responses were summarized, the patients got marked 
relief were 12 (80%) and 13 (86.67%) from Group A and B respectively. There were 3 (20%) and 2 (13.33%) patients 
who got moderate relief from Group A and B respectively. 
MVC
BT 15 89.047 8.641 2.231 -1.237 0.236
AT 15 90 7.819 2.019
Difference 15 -0.953 2.984 0.77
MCHC
BT 15 32.567 1.375 0.355 0.216 0.832
AT 15 32.459 2.074 0.536
Difference 15 0.107 1.925 0.497
Parameter Tre a t m e n t Name N Mean Std Dev SEM T value P value
HB% Group A 15 12.567 1.607 0.415 -1.081 0.289Group B 15 13.313 2.14 0.552
TLC Group A 15 6226.667 1084.611 280.045 -1.240 0.225Group B 15 6800 1424.781 367.877
N Group A 15 6226.667 1084.611 280.045 -0.750 0.460Group B 15 6800 1424.781 367.877
L Group A 15 37.6 6.045 1.561 1.507 0.143Group B 15 34.467 5.317 1.373
Total RBC Group A 15 4.753 0.691 0.178 0.569 0.574Group B 15 4.611 0.676 0.175
MCH Group A 15 25.9 5.487 1.417 -1.869 0.072Group B 15 29.013 3.396 0.877
MCHC Group A 15 32.44 2.224 0.574 -0.188 0.853Group B 15 32.567 1.375 0.355
Parameter Tre a t m e n t Name N Mean Std Dev SEM T value P value
HB% Group A 15 12.387 1.603 0.414 -1.527 0.138Group B 15 13.313 2.14 0.552
N Group A 15 59.867 6.278 1.621 -0.584 0.564Group B 15 61.4 8.007 2.067
L Group A 15 36.267 5.97 1.541 1.392 0.175Group B 15 32.8 7.58 1.957
Total RBC Group A 15 4.803 0.672 0.174 0.719 0.478Group B 15 4.625 0.688 0.178
MCV Group A 15 77.067 11.56 2.985 -3.589 0.001Group B 15 90 7.819 2.019
MCH Group A 15 25.8 5.343 1.38 -2.151 0.040Group B 15 29.167 2.86 0.739
MCHC Group A 15 33.113 2.658 0.686 0.751 0.459Group B 15 32.459 2.074 0.536
ESR Group A 15 18 9 45 226.500 0.820Group B 15 25 8.25 33.75
Range Group A Group B Total
Controlled 100% 0(0%) 0(0%) 0(0%)
Marked Relief ≥75% 12(80%) 13(86.67%) 25(83.33%)
Moderate Relief ≥50-74% 3(20%) 2(13.33%) 5(16.67%)
Mild Relief ≥25-49% 0(0%) 0(0%) 0(0%)
No Relief <25% 0(0%) 0(0%) 0(0%)
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Harms  
No any types of adverse event were noted in 
both groups during this trial which shows the safety 
nature of both interventions. 
Discussion 
Probable Mode of action of Panchatikta Ghrita  
As cervical spondylosis is Asthi majja 
pradoshaja Vikara as per description of Acharya 
Charaka that Basti with Sarpi medicated with 
Panchtikta dravya is more beneficial in such entities. 
Matrabasti is one of the types of Snehabasti which does 
snehana as a first line of treatment in Sandhigata vata 
told by Acharya Sushruta. As Goghrita is Vatapittahara 
and when it is medicated with Panchtikta dravya it 
becomes Tridoshahara. The ingredients of the 
Panchtikta Ghrita is chiefly having Vedanasthapana /
Shoolaprashamana effect (Guduchi, Nimba, Vasa, 
Kantakari, ksheerasarpi) Shothahara (Nimba, Vasa, 
Kantakari) Vatahara (Patola, Kantakari, Ksheerasarpi) 
Balya /Bhr imana (Guduch i , N imba , Pa to la , 
ksheerasarpi) Rasayana effect (Guduchi, Nimba, Vasa, 
Ksheerasarpi). The Ghrita is nullifies the effect of 
Rukshata and Laghuta of Tikta rasa retaining the 
Kharatva, which is absolutely helpful to correct the 
Asthi Dhatu which then corrects the disease progress 
(21).  
Ghri ta i s Vata-p i t tashamaka , Ba lya , 
Agnivardhaka, Madhura, Saumya, Sheeta Virya, Shula, 
Jwarahara, Vrishya and Vayasthapaka also. Thus, it 
pacifies the Vata, improve the general condition of the 
body and acts as a rejuvenator of the body. Thus, helps 
in the Samprapti Vighatana of the Manyasthmbha. As 
well it is having property like Yogavahi which is helpful 
in increase bio-availability of other drugs without losing 
its own property. It also contains vitamin D which plays 
an important role to utilize calcium and phosphorous in 
blood and bone building. In addition to above 
antioxidant properties of Ghrita, it prevents the 
oxidative damage of various tissues & thus provides 
protection from various degenerative conditions (22).  
As Panchtikta Ghrita is main medication in 
both groups nourishes the nerves due to its Snigdha 
property. As it is a type of ketogenic diet and prevents 
stiffness of the nerves, muscles in regions of neck, 
shoulders and arms which ultimately results in 
significant reduction in Stiffness &Pain. Consistency in 
relief even after stoppage of procedures in both groups 
& significant reduction in severity of symptoms as well 
as reduction in neck disability shows that Panchtikta 
Ghrita is anti-inflammatory in nature, it may reduce or 
checks over further degenerative changes of the cervical 
spines due to its Bruhana nature also (23).  
Probable mode of action of Matra Vasti  
Matravasti with Panchtikta Ghrita is helpful to 
induce Anulomana of the vitiated Vata Dosha which is 
responsible for Pain i.e. Manyashoola. Dalhana says 
that Pureeshadhara Kala and Asthidhara Kala are one 
and the same. So, we can assume that if we administer 
drug to the rectum (Pureeshadhara Kala); the 
Asthivaha Srotas also get nurtured (24). 
Probable mode of action of Nasya  
Nasya therapy is considered as best therapy for 
the diseases or pathologies lying above the clavicle 
(25).  As nose is gateway of brain as per Acharya 
Vagbhata and all medications administered to nasal 
orifice, it gets passed to brain & reaches to the 
surrounding areas of head & neck, after that it affects 
over various Dosha in those areas and checks over 
pathologies situated in particular region (26).  
In the present study maximum  patients were 
females & incidence rate of cervical spondylosis is 
more in female which is supported by  Ali M. Alsham et 
.al.2015 stating that Cervical spondylosis is  common 
(~30%) in the >30 age groups &  prevalence of it is 
more in women (7.8% and 76.2%) than in men (73.9% 
and 3.3%) (27).  
Insignificant result in radiological improvement 
in Cervical X -ray spines was found due to due to 
minimum duration of intervention and study. As both 
interventions in two groups in current clinical study was 
given for only 7 days for sample size. As minimum 21 
days are required to reach medicine through Rasa dhatu 
to Asthi dhatu which is assessed through X-ray cervical 
spines (28). 
Statistically reduction in ESR in both the 
groups just after interventions reflects the anti-
inflammatory action of Panchtikta Ghrita since there is 
no significant difference between both the groups. 
More significant effect found in Group B may 
be due to additional local massage & sudation therapies 
over face, neck & shoulder which was done as a 
preprocedural of Marsh Nasya & which ultimately 
improve blood circulation in local area, which provides 
greater nourishment to this part. Both these therapies 
alleviate the Rukshata & Sthmabha induced due to Vata 
& Kapha Prakopa. Local Swedana therapy with 
Nirgundi qwatha over cervical region may helpful to 
relieve pain, which decreases the intensity of 
Manyashoola due to its Vata-Kapha hara properties 
(29).  
Simultaneously Dhoomapana with Haridra was 
also given to all patients recruited in group B for 7 days 
as a part of post-procedure protocol of Nasya therapy. 
Likewise, it may be helpful to pacify Kapha Dosha in 
Cervical region. 
Generalizability   
From this clinical trial, considering the 
significant effectiveness of both interventions in 
patients with Cervical spondylosis, further multicentric 
study can be planned with large sample size. Duration 
of both interventions can be increased by 14 to 21 days 
for perusal the significant changes in Radiological 
investigation i.e. X Ray cervical spine.  
Interpretation 
Both groups have given a highly significant 
improvement in reducing symptoms of cervical 
spondylosis & reduction in Neck disability index. While 
comparing between two groups, it was also statistically 
proved that Nasya with Panchtikta Ghrita is more 
effective than Matra Vasti with Panchtikta Ghrita in 
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reducing symptoms of cervical spondylosis & 
improvement in NDI scale. Both interventions are 
proved as safe i.e. without causing any undue effects. 
Though rectal route of drug administration is more 
effective than other routes, however, many conditions 
such as anal fissure or piles, proctitis are certain 
contraindications for this type of therapy i.e. this 
principle is exactly applicable for Matra Vasti also. 
Many times, especially female patients are more 
reluctant to undergo such type of anal root therapy. In 
such cases, Nasya therapy will be the alternative option 
for the patients. In addition to above, Nasya therapy is 
quite cost effective than that of Matra Vasti as it 
requires comparative less amount of drug as well as 
dietic restrictions, only lifestyle modification advised 
during Nasya therapy is quite easy to follow in 
comparison with Matra Vasti. Duration of such 
restrictions are also less as compared to that of Matra 
Vasti. Because in Matra Basti, restrictions should be 
double the duration of intervention of therapy. 
Conclusion 
With reference to all findings it is concluded 
that in Group B, intervention with Marsh Nasya with 
Panchtikta Ghrita is more effective to reduce the 
severity of symptoms of Cervical spondylosis as well as 
effective in reducing neck disability index than that of 
Group A, intervention of Matra Vasti with Panchtikta 
Ghrita.  
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